Cargando…
Rapid-onset clozapine-induced loss of glycaemic control: case report
Clozapine has proved to be an effective antipsychotic for the treatment of refractory schizophrenia – characterised by the persistence of symptoms despite optimal treatment trials with at least two different antipsychotics at adequate dose and duration – but its use is hampered by adverse effects. T...
Autores principales: | Porras-Segovia, Alejandro, Krivoy, Amir, Horowitz, Mark, Thomas, George, Bolstridge, Mark, Ion, Dragos, Shergill, Sukhwinder S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal College of Psychiatrists
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425930/ https://www.ncbi.nlm.nih.gov/pubmed/28507773 http://dx.doi.org/10.1192/bjpo.bp.117.004481 |
Ejemplares similares
-
Outcomes in treatment-resistant schizophrenia: symptoms, function and
clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021) -
Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia
por: Foster, Jessica, et al.
Publicado: (2017) -
Inflammatory response to clozapine in the absence of myocarditis: case report
por: Davey, Patrick, et al.
Publicado: (2016) -
When the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity
por: Lowe, Penelope, et al.
Publicado: (2017) -
Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment
por: Gee, Siobhan, et al.
Publicado: (2015)